Ganoderma

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100050538	2021-09-01	2021-08-28	Clinical study of Ganodermalucidum extract in the treatment of motor and non motor symptoms in patie ...	Clinical study of Ganodermalucidum extract in the treatment of motor and non motor symptoms in patie ...	Parkinson's disease	Experimental group:Reishi Mushroom Extract Treatment;Control group:None;	Xuanwu Hospital of Capital Medical University	NULL	Recruiting	18	80	Both	Experimental group:30;Control group:30;		China
2	NCT03594656 (ClinicalTrials.gov)	July 15, 2018	11/7/2018	Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease	Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease: A Mu ...	Parkinson Disease	Drug: Ganoderma;Drug: Placebos	Xuanwu Hospital, Beijing	NULL	Recruiting	30 Years	80 Years	All	288	Phase 3	China
3	NCT00224263 (ClinicalTrials.gov)	September 2005	20/9/2005	Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease	A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety ...	Parkinson's Disease	Drug: Lingzhi (Ganoderma)	Xuanwu Hospital, Beijing	NULL	Completed	30 Years	80 Years	Both	360	Phase 2	China

First Previous1Next Last